Literature DB >> 30014550

The SNP43 (G/A) polymorphism in CAPN10 gene confers an increased risk of cognitive impairment in cerebral small vessel disease.

Kai Wu1, Ying Cai1.   

Abstract

BACKGROUND: Cognitive impairment, significantly reducing processing speed and executive function, is the critical consequence of cerebral small vessel disease (SVD), in which genetic variations have been studied. In this study, we explore the role of SNP43 (G/A) and SNP63 (C/T) polymorphism in the CAPN10 on cognitive impairment process in cerebral SVD.
METHODS: Cerebral SVD patients (n = 224) and healthy controls (n = 187) were recruited. The relationship between frequency distribution of SNP43 (G/A) and SNP63 (T/C) genotype and allele in CAPN10 gene, and cognitive impairment was examined. The independent risk factors for cognitive impairment in SVD were determined by logistic regression analysis.
RESULTS: Accordingly, the frequency distribution of genotype and allele at SNP43 (G/A) was significantly different between cerebral SVD patients and healthy controls. Cerebral SVD patients with GG genotype were more susceptible for cognitive impairment, whereas cerebral SVD patients with GA + AA genotype were less possible to suffer from cognitive impairment, compared with those with GG genotype. And also, cerebral SVD does not include SNP63 (C/T) to associate with cognitive impairment, and SNP43 (G/A), total cholesterol, triglyceride, low-density lipoprotein, and high-density lipoprotein were independent risk factors for cognitive impairment in SVD.
CONCLUSION: Our study provides evidence that SNP43 (G/A) in the CAPN10 gene increases the risk of cognitive impairment in SVD patients. Besides it is proven that, patients with G allele are more susceptible to suffer from cerebral SVD with worse cognitive impairment.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  CAPN10 gene; SNP43 (G/A); SNP63 (C/T); allele; cerebral small vessel disease; cognitive impairment; polymorphism

Mesh:

Substances:

Year:  2018        PMID: 30014550      PMCID: PMC6816906          DOI: 10.1002/jcla.22615

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  37 in total

1.  Increased intracellular calpain detection in experimental focal cerebral ischemia.

Authors:  M Liebetrau; B Staufer; E A Auerswald; D Gabrijelcic-Geiger; H Fritz; C Zimmermann; T Pfefferkorn; G F Hamann
Journal:  Neuroreport       Date:  1999-02-25       Impact factor: 1.837

Review 2.  Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges.

Authors:  Leonardo Pantoni
Journal:  Lancet Neurol       Date:  2010-07       Impact factor: 44.182

3.  New evidence for the role of calpain 10 in autosomal recessive intellectual disability: identification of two novel nonsense variants by exome sequencing in Iranian families.

Authors:  Morteza Oladnabi; Luciana Musante; Farzaneh Larti; Hao Hu; Seyedeh Sedigheh Abedini; Thomas Wienker; Hans Hilger Ropers; Kimia Kahrizi; Hossein Najmabadi
Journal:  Arch Iran Med       Date:  2015-03       Impact factor: 1.354

4.  Arg972 insulin receptor substrate-1 polymorphism and risk and severity of Alzheimer's disease.

Authors:  Wei Wang; Liang Yang; Liming Tan; Xiaomei Wu; Bo Jiang; Xiangmin Shen
Journal:  J Clin Neurosci       Date:  2013-12-19       Impact factor: 1.961

5.  Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels.

Authors:  Marju Orho-Melander; Mia Klannemark; Malin K Svensson; Martin Ridderstråle; Cecilia M Lindgren; Leif Groop
Journal:  Diabetes       Date:  2002-08       Impact factor: 9.461

6.  Expression and cellular localisation of calpain-like proteins in Trypanosoma brucei.

Authors:  Wen Liu; Katinka Apagyi; Lorraine McLeavy; Klaus Ersfeld
Journal:  Mol Biochem Parasitol       Date:  2009-09-17       Impact factor: 1.759

7.  The Brief Memory and Executive Test (BMET) for detecting vascular cognitive impairment in small vessel disease: a validation study.

Authors:  Rebecca L Brookes; Matthew J Hollocks; Usman Khan; Robin G Morris; Hugh S Markus
Journal:  BMC Med       Date:  2015-03-11       Impact factor: 8.775

8.  Relationship between plasma lipids and mild cognitive impairment in the elderly Chinese: a case-control study.

Authors:  Qian He; Qing Li; Jiangang Zhao; Tianfeng Wu; Lu Ji; Guowei Huang; Fei Ma
Journal:  Lipids Health Dis       Date:  2016-09-05       Impact factor: 3.876

Review 9.  Dysregulation of Calpain Proteolytic Systems Underlies Degenerative Vascular Disorders.

Authors:  Takuro Miyazaki; Akira Miyazaki
Journal:  J Atheroscler Thromb       Date:  2017-08-17       Impact factor: 4.928

10.  Risk of vascular events in different manifestations of cerebral small vessel disease: A 2-year follow-up study with a control group.

Authors:  Jacek Staszewski; Renata Piusińska-Macoch; Bogdan Brodacki; Ewa Skrobowska; Katarzyna Macek; Adam Stępień
Journal:  Heliyon       Date:  2017-11-21
View more
  2 in total

1.  The SNP43 (G/A) polymorphism in CAPN10 gene confers an increased risk of cognitive impairment in cerebral small vessel disease.

Authors:  Kai Wu; Ying Cai
Journal:  J Clin Lab Anal       Date:  2018-07-16       Impact factor: 2.352

2.  The Association Between the rs2975760 and rs3792267 Single Nucleotide Polymorphisms of Calpain 10 (CAPN10) and Gestational Diabetes Mellitus.

Authors:  Xia Zhang; Chunhong Shi; Lili Wei; Fengyun Sun; Li Ji
Journal:  Med Sci Monit       Date:  2019-07-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.